Introducing The Ellipsys Vascular Access System.
A minimally invasive approach to AV fistula creation.
A minimally invasive approach to AV fistula creation.
The Ellipsys® Vascular Access System has received FDA approval in the U.S. and European CE Mark approval for the creation of an arteriovenous fistula in patients with chronic kidney disease requiring hemodialysis.
2,500,000
2.5 million hemodialysis patients worldwide
Patient population growing at 8% per year
3,400,000
3.4 million hemodialysis patients worldwide by 2020
“For vascular access, Ellipsys is a paradigm shift of the highest order.”
Thomas J. Fogarty, MD
See it in action.
